Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

The administration of azacitidine (AZA) was found to be more effective than conventional care regimen (CCR) in patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML) with lower blast count. We designed a study to determine e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pathol Oncol Res
Egile Nagusiak: Helbig, Grzegorz, Chromik, Karolina, Woźniczka, Krzysztof, Kopińska, Anna J., Boral, Kinga, Dworaczek, Martyna, Koclęga, Anna, Armatys, Anna, Panz-Klapuch, Marta, Markiewicz, Mirosław
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Netherlands 2019
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6614132/
https://ncbi.nlm.nih.gov/pubmed/30613922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-018-00574-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak